Business Wire Feed
Centauri Therapeutics Extends Series A to £30M With £6M Investment From AMR Action Fund to Support Progression of Lead Clinical Candidate
Clinical candidate in ABX-01 programme, CTX-187, currently in development ahead of first in-human clinical trials to target Gram-negative bacterial infections Investment from the world’s largest venture capital fund focused exclusively on antimicrobial therapeutics and diagnostics more...
BioMed Realty and Babraham Research Campus Ltd Complete Lease-Up of Newest Building at Babraham Research Campus, with TRIMTECH Therapeutics and Tagomics
CAMBRIDGE, England--(BUSINESS WIRE)--BioMed Realty, the largest private operator of real estate for the life science and technology industries, today announced the completion of the lease-up of the newest laboratory building at Babraham Research Campus, following more...
Epredia and Mindpeak Announce EU Distribution Agreement for AI-Powered Image Recognition in Cancer Diagnostics
Epredia will add Mindpeak AI modules for pathology to its digital pathology portfolio, offering enhanced precision and speed in diagnostic image reviewRUNCORN, United Kingdom--(BUSINESS WIRE)--#AI--Epredia, a global leader in precision cancer diagnostics and a subsidiary more...
Ambience Healthcare Recognized as 2026 KLAS/CHIME Trailblazer Award Winner
SAN FRANCISCO--(BUSINESS WIRE)--Ambience Healthcare, the leading intelligence platform for clinical documentation and revenue integrity, today announced it has been named the 2026 KLAS/CHIME Trailblazer Award winner. Now in its second year, the Trailblazer Award recognizes more...
Vir Biotechnology Reports Positive Updated Phase 1 Results for PSMA-targeting, PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 in Patients with Metastatic Prostate Cancer
– Updated Phase 1 dose-escalation data (n=58) show VIR-5500 monotherapy has a favorable safety profile and was well tolerated with no dose-limiting toxicities observed to date – Dose-dependent anti-tumor activity was observed, with 82% PSA50 more...
Arcus Presents New Data for its HIF-2a Inhibitor Casdatifan, Which Showed Progression-Free Survival Beyond One Year in Late-Line Kidney Cancer
Median progression-free survival (mPFS) was 15.1 months, and the confirmed overall response rate (cORR) increased to 45% for the 100mg QD (once daily) tablet cohort in an updated analysis of the ARC-20 study In a more...
Flatiron Health Attends the 2026 American Society of Genitourinary Cancers Symposium to Answer Oncology’s Most Critical Questions
New research from prostate and bladder cancer Panoramic datasets offers pathways for optimized patient-centered care NEW YORK--(BUSINESS WIRE)--Flatiron Health today announced its presence at the American Society of Genitourinary Cancers Symposium happening from February 26-28, more...
AngioDynamics to Present at the Leerink Partners Global Healthcare Conference
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today more...
Ant Group’s Alipay AI Pay and AI Health App AQ Each Surpass 100 Million Users During CNY as AI Adoption Accelerates in China
HANGZHOU, China--(BUSINESS WIRE)--As AI adoption gained momentum during the 2026 Chinese New Year, Ant Group announced today that both Alipay AI Pay and its AI health app AQ have each surpassed the 100 million user more...
AOP Health on Rare Diseases: Information. Collaboration. Innovation.
Why closing knowledge gaps matters for patients, healthcare and innovation.VIENNA--(BUSINESS WIRE)--#AOPHealth--Between 27 and 36 million1 people in Europe are living with a rare disease, yet only around six percent currently have access to an approved more...
ŌURA Named Official Wearable of Team Finland
SAN FRANCISCO--(BUSINESS WIRE)--ŌURA, maker of the world’s leading smart ring, Oura Ring, today announced a long-term partnership as the Official Wearable of Team Finland. As the exclusive provider in the category of continuous health and more...
Almirall’s 2025 Results
Almirall meets guidance for 2025, delivering 12.4% net sales growth and further pipeline progress, continuing its sustained growth trajectory with strong dermatology performance and commercial execution in Europe Almirall delivered net sales growth in 2025 more...
Virion Therapeutics Reports Broad and Sustained Anti-HBV Immunity Following a Single VRON-0200 Dose in the Majority of Chronically HBV-Infected Patients From its Phase 1b Study at CROI 2026
PHILADELPHIA--(BUSINESS WIRE)--Virion Therapeutics, LLC, a clinical-stage biotechnology company developing novel T cell-based immunotherapies that utilize checkpoint modifiers, today announced at the 33rd Conference on Retroviruses and Opportunistic Infections (CROI), in Denver, CO, that a single more...
Exact Sciences Stockholders Approve Acquisition by Abbott
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corporation (NASDAQ: EXAS) (“Exact Sciences”), a leading provider of cancer screening and diagnostic tests, today announced that its stockholders voted to approve the proposed acquisition of Exact Sciences by Abbott (NYSE: more...
Science Corp. and Neurosoft Bioelectronics Announce Novel BCI Ecosystem Partnership
Deal Joins Science’s World-Class BCI Tools with Neurosoft’s Leading Neural Data PlatformALAMEDA, Calif. & GENEVA--(BUSINESS WIRE)--Science Corporation, the pioneering full-stack neural engineering company focused on restoring and extending life, and Neurosoft Bioelectronics, a neural data more...
WestFax Launches AI-Powered Intelligent Document Processing Platform for Healthcare
WestFax Comprehend Now Available Across All Service Tiers, Automating Medical Document Classification, Data Extraction and Workflow RoutingCENTENNIAL, Colo.--(BUSINESS WIRE)--WestFax, a provider of HIPAA-compliant cloud fax and healthcare document exchange solutions, today announced the official launch more...
ALIS Releases New Clinical Benchmarking Report Analyzing Data From 28,800 Senior Living Residents
CHICAGO--(BUSINESS WIRE)--ALIS, the leading senior living intelligent eHR software, today announced the release of The ALIS 500 Clinical Report: Q4 2025, the industry’s first-of-its-kind clinical benchmarking report built specifically for assisted living, memory care, and more...
Acadia Healthcare to Participate in March Investor Conferences
FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in three investor conferences in March. On Monday, March 2, 2026, the Company will participate in the Raymond James & more...
Dr. Reddy’s Announces USFDA Acceptance to Review Its Biologics License Application (BLA) for Proposed Interchangeable Biosimilar, Abatacept
Following the submission in December 2025, USFDA has accepted Dr. Reddy’s 351(k) Biologics License Application (BLA) for Proposed Interchangeable biosimilar Abatacept, DRL_AB (IV for Infusion) BLA is based on a robust data package supporting similarity more...
Amanda Free Named President, Anthem Blue Cross and Blue Shield of Georgia
Georgia healthcare leader brings deep market expertise, operational excellence, and strong community relationshipsATLANTA--(BUSINESS WIRE)--Anthem Blue Cross and Blue Shield of Georgia today announced that Amanda Free has been named President. “Amanda is a trusted Georgia more...
Quanterix To Report Fourth Quarter and Full Year 2025 Financial Results on March 2, 2026
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (Nasdaq: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that it will host a conference call on Monday, March 2, 2026, at 4:30 p.m. more...
Cerus Corporation to Participate in the TD Cowen 46th Annual Health Care Conference
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced today that members of the Company’s management are scheduled to present at the TD Cowen 46th Annual Health Care Conference on Tuesday, March 3, 2026, at 10:30 a.m. more...
Jessica Lopez-Liggett Named President of Anthem Blue Cross and Blue Shield in Indiana
20-year healthcare industry veteran will lead Anthem’s Commercial business organization in IndianaINDIANAPOLIS--(BUSINESS WIRE)--Anthem Blue Cross and Blue Shield in Indiana has named Jessica Lopez-Liggett as Commercial State Plan President. She succeeds Beth Keyser, who now more...
Scientific Evidence Demonstrates OPTAVIA®’s Metabolic Health Benefits, Opening the Door to Qualified HSA/FSA Clients
BALTIMORE--(BUSINESS WIRE)--As part of its continued focus on improving metabolic health, Medifast® (NYSE: MED) today announced that OPTAVIA’s comprehensive metabolic health system is available for reimbursement on select insurance plans using Health Savings Accounts (HSA) more...
ImmunityBio Partners with Biopharma and Cigalah Healthcare to Launch ANKTIVA® in Saudi Arabia for Bladder and Lung Cancer Patients
Biopharma & Cigalah are two of the largest pharmaceutical commercial distributors in the Middle East and North Africa (MENA) ImmunityBio established a wholly owned subsidiary in the Kingdom of Saudi Arabia to support physicians and more...